Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Colorcon
Mallinckrodt

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Patent: 9,078,929

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,078,929
Title:.epsilon.-Polylysine conjugates and the use thereof
Abstract: The present invention relates to .epsilon.-polylysine conjugates, in particular conjugates of .epsilon.-polylysine with compounds carrying carboxyl groups, and to the preparation and use thereof for targeting of the kidney.
Inventor(s): Kuebelbeck; Armin (Bensheim, DE), Larbig; Gregor (Gelnhausen, DE), Mier; Walter (Bensheim, DE), Beijer; Barbro (Nussloch, DE), Haberkorn; Uwe (Schwetzingen, DE)
Assignee: Merck Patent GmbH (Darmstadt, DE)
Application Number:13/384,789
Patent Claims:see list of patent claims

Details for Patent 9,078,929

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Merck Patent GmbH (Darmstadt, DE) 2029-07-20 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Merck Patent GmbH (Darmstadt, DE) 2029-07-20 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial Merck Patent GmbH (Darmstadt, DE) 2029-07-20 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKinsey
Johnson and Johnson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.